MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.255
-0.055 (-4.20%)
Nov 6, 2026, 3:55 PM EST - Market open
MaxCyte Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 31.05 | 33.03 | 38.63 | 41.29 | 44.26 | 33.89 | |
Revenue Growth | -13.15% | -14.50% | -6.44% | -6.72% | 30.59% | 29.52% |
Cost of Revenue | 6.45 | 6.22 | 7.1 | 4.74 | 5.1 | 3.65 |
Gross Profit | 24.6 | 26.8 | 31.53 | 36.55 | 39.16 | 30.25 |
Selling, General & Admin | 38.22 | 46.29 | 56.19 | 57.04 | 44.48 | 31.68 |
Research & Development | 16.76 | 20.82 | 22.23 | 23.82 | 19.51 | 15.41 |
Operating Expenses | 59.03 | 71.34 | 82.56 | 84.85 | 66.52 | 48.44 |
Operating Income | -34.43 | -44.53 | -51.03 | -48.3 | -27.36 | -18.19 |
Interest Expense | - | - | - | - | - | -0.4 |
Interest & Investment Income | 6.16 | 7.27 | 10.14 | 10.38 | 3.92 | 0.15 |
Other Non Operating Income (Expenses) | - | - | - | - | -0.13 | -0.65 |
EBT Excluding Unusual Items | -28.27 | -37.27 | -40.89 | -37.92 | -23.57 | -19.08 |
Merger & Restructuring Charges | -3.81 | -3.81 | -0.16 | - | - | - |
Impairment of Goodwill | -3.55 | -3.55 | - | - | - | - |
Pretax Income | -35.64 | -44.63 | -41.06 | -37.92 | -23.57 | -19.08 |
Net Income | -35.64 | -44.63 | -41.06 | -37.92 | -23.57 | -19.08 |
Net Income to Common | -35.64 | -44.63 | -41.06 | -37.92 | -23.57 | -19.08 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 107 | 106 | 105 | 103 | 102 | 91 |
Shares Outstanding (Diluted) | 107 | 106 | 105 | 103 | 102 | 91 |
Shares Change | 0.95% | 1.51% | 1.53% | 1.54% | 12.23% | 30.45% |
EPS (Basic) | -0.33 | -0.42 | -0.39 | -0.37 | -0.23 | -0.21 |
EPS (Diluted) | -0.33 | -0.42 | -0.39 | -0.37 | -0.23 | -0.21 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -23.64 | -36.18 | -29.26 | -25.39 | -33.26 | -14.51 |
Free Cash Flow Per Share | -0.22 | -0.34 | -0.28 | -0.25 | -0.33 | -0.16 |
Gross Margin | 79.23% | 81.16% | 81.62% | 88.52% | 88.48% | 89.24% |
Operating Margin | -110.88% | -134.84% | -132.12% | -116.98% | -61.82% | -53.66% |
Profit Margin | -114.77% | -135.14% | -106.29% | -91.85% | -53.25% | -56.30% |
Free Cash Flow Margin | -76.14% | -109.54% | -75.75% | -61.48% | -75.14% | -42.82% |
EBITDA | -30.29 | -40.22 | -46.72 | -44.13 | -24.66 | -16.76 |
EBITDA Margin | -97.54% | -121.79% | -120.95% | -106.88% | -55.72% | -49.46% |
D&A For EBITDA | 4.14 | 4.31 | 4.32 | 4.17 | 2.7 | 1.42 |
EBIT | -34.43 | -44.53 | -51.03 | -48.3 | -27.36 | -18.19 |
EBIT Margin | -110.88% | -134.84% | -132.12% | -116.98% | -61.82% | -53.66% |